Afficher la notice abrégée

Prevention of post-concussion-like symptoms in patients presenting at the emergency room, early single eye movement desensitization, and reprocessing intervention versus usual care: study protocol for a two-center randomized controlled trial

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGIL-JARDINE, Cedric
dc.contributor.authorAL JOBOORY, Samantha
dc.contributor.authorJAMMES, J. T. S.
dc.contributor.authorDURAND, G.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRIBEREAU-GAYON, Regis
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGALINSKI, Michel
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSALMI, Louis Rachid
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorREVEL, Philippe
dc.contributor.authorREGIS, C. A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorVALDENAIRE, Guillaume
dc.contributor.authorPOULET, E.
dc.contributor.authorTAZAROURTE, K.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLAGARDE, Emmanuel
dc.date.accessioned2020-11-10T13:35:11Z
dc.date.available2020-11-10T13:35:11Z
dc.date.issued2018-10-12
dc.identifier.issn1745-6215 (Electronic) 1745-6215 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/12206
dc.description.abstractEnBACKGROUND: Recent data suggest that 10-20% of injury patients will suffer for several months after the event from diverse symptoms, generally referred to as post-concussion-like symptoms (PCLS), which will lead to a decline in quality of life. A preliminary randomized control trial suggested that this condition may be induced by the stress experienced during the event or emergency room (ER) stay and can be prevented in up to 75% of patients with a single, early, short eye movement desensitization and reprocessing (EMDR) psychotherapeutic session delivered in the ER. The protocol of the SOFTER 3 study was designed to compare the impact on 3-month PCLS of early EMDR intervention and usual care in patients presenting at the ER. Secondary outcomes included 3-month post-traumatic stress disorder, 12-month PCLS, self-reported stress at the ER, self-assessed recovery expectation at discharge and 3 months, and self-reported chronic pain at discharge and 3 months. METHODS: This is a two-group, open-label, multicenter, comparative, randomized controlled trial with 3- and 12-month phone follow-up for reports of persisting symptoms (PCLS and post-traumatic stress disorder). Those eligible for inclusion were adults (>/=18 years old) presenting at the ER departments of the University Hospital of Bordeaux and University Hospital of Lyon, assessed as being at high risk of PCLS using a three-item scoring rule. The intervention groups were a (1) EMDR Recent Traumatic Episode Protocol intervention performed by a trained psychologist during ER stay or (2) usual care. The number of patients to be enrolled in each group was 223 to evidence a 15% decrease in PCLS prevalence in the EMDR group. DISCUSSION: In 2012, the year of the last national survey in France, 10.6 million people attended the ER, some of whom did so several times since 18 million visits were recorded in the same year. The SOFTER 3 study therefore addresses a major public health challenge. TRIAL REGISTRATION: Clinical Trials. NCT03400813 . Registered 17 January 2018 - retrospectively registered.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enIETO
dc.title.enPrevention of post-concussion-like symptoms in patients presenting at the emergency room, early single eye movement desensitization, and reprocessing intervention versus usual care: study protocol for a two-center randomized controlled trial
dc.title.alternativeTrialsen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s13063-018-2902-2en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30314512en_US
bordeaux.journalTrialsen_US
bordeaux.page555en_US
bordeaux.volume19en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamIETOen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03164960
hal.version1
hal.date.transferred2021-03-10T11:14:57Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Trials&rft.date=2018-10-12&rft.volume=19&rft.issue=1&rft.spage=555&rft.epage=555&rft.eissn=1745-6215%20(Electronic)%201745-6215%20(Linking)&rft.issn=1745-6215%20(Electronic)%201745-6215%20(Linking)&rft.au=GIL-JARDINE,%20Cedric&AL%20JOBOORY,%20Samantha&JAMMES,%20J.%20T.%20S.&DURAND,%20G.&RIBEREAU-GAYON,%20Regis&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
BPH_Trials_2018_Gil-Jardiné.pdf
Taille:
1009.Ko
Format:
PDF
Voir/Ouvrir
Thumbnail
Nom:
license_rdf
Taille:
914octets
Format:
application/rdf+xml
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée